Covista Inc. (CVSA) Stock Price & Analysis
Covista Inc. (CVSA) closed at USD 131.62 on Thursday, October 22, 2026, up 3.70% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 131.62; the Oct 22, 2026 session ranged USD 127.42–132.1 on volume of 204,987 shares. Market capitalization is —, with a 52-week range of USD 86.97–156.26 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:26 UTC.
Also available as compact Markdown for AI agents: nexqual.com/CVSA.md
Key facts (CVSA)
- Last four reported quarters (through Jun 30, 2026): revenue $1.95B, net income $252M (12.9% margin), free cash flow $393M (SEC filings).
- 1 of 80 tracked superinvestors hold CVSA (13F, Q2 2026): 0 new, 0 added, 1 reduced, 0 unchanged.
- Total return with dividends: 1Y -14.0% vs S&P 500 +14.9%; 5Y +257.7% vs S&P 500 +80.3%.
- Next earnings: 2026-10-29, EPS estimate USD 1.83, revenue estimate $491M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (CVSA)
| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $1.38B | $1.45B | $1.58B | $1.79B | $1.95B | $1.95B |
| Gross profit | $722M | $802M | $886M | $1.02B | $1.12B | — |
| Operating income | $76.7M | $168M | $217M | $342M | $383M | $383M |
| Net income | $311M | $93.4M | $137M | $237M | $252M | $252M |
| EPS (diluted) | $6.43 | $2.05 | $3.39 | $6.18 | $7.04 | — |
| Free cash flow | -$20.5M | $166M | $247M | $288M | $393M | $393M |
| Gross margin | 52.3% | 55.3% | 55.9% | 56.9% | 57.3% | — |
| Operating margin | 5.6% | 11.6% | 13.7% | 19.1% | 19.6% | 19.6% |
| Net margin | 22.5% | 6.4% | 8.6% | 13.3% | 12.9% | 12.9% |
| Revenue growth | +53.7% | +5.0% | +9.2% | +12.9% | +9.3% | — |
| Cash + short-term investments | — | $272M | $219M | $200M | $406M | — |
| Total debt | $839M | $695M | $649M | $553M | $663M | — |
Fiscal years end Jun. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (CVSA)
P/E at fiscal year-ends: Jun 2026 17.7x, Jun 2025 20.6x, Jun 2024 20.1x.
Superinvestors (SEC 13F-HR, Q2 2026) (CVSA)
1 of 80 tracked investors hold CVSA. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| John Rogers | Ariel Investments | 2.20% | $221M | Reduced -8.3% |
Analysts (CVSA)
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-05 | BMO Capital | Target lowered | Outperform | $148 → $145 |
| 2026-09-03 | Truist Securities | Downgrade | Buy → Hold | $140 |
Total return (dividends reinvested) (CVSA)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | -14.0% | +257.7% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -14.0% | +28.9% |
| Volatility (annualized) | 57.1% | 45.0% |
| Max drawdown | -42.0% (Oct 2025→Nov 2025) | -43.8% (Oct 2021→Feb 2022) |
CVSA analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $1.83 | $1.79 | +2.1% | $490.7M | 4 |
| Next quarter (ends Dec 2026) | $2.40 | $2.60 | -7.7% | $519.8M | 4 |
| Current fiscal year (ends Jun 2027) | $9.04 | $8.89 | +1.8% | $2.07B | 4 |
| Next fiscal year (ends Jun 2028) | $10.01 | $9.96 | +0.5% | $2.22B | 4 |
Key Statistics (as of October 23, 2026 at 09:26 UTC)
| Price | USD 131.62 |
|---|---|
| Change | ▲ 3.70% (up) |
| Previous Close | USD 131.62 |
| Open | USD 131.62 |
| Day Range | USD 127.42 – 132.1 |
| 52-Week Range | USD 86.97 – 156.26 |
| Volume | 204,987 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (CVSA)
Nexqual's technical model rates CVSA "BUY" based on 5 bullish and 1 bearish signals across 127 daily candles, as of October 23, 2026 at 09:26 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 60.61 (neutral) |
| vs SMA50 | Above (USD 128.21) |
| MACD | 0.73 (positive) |
Earnings (CVSA)
| Next Earnings Date | 2026-10-29 |
|---|---|
| EPS Estimate | USD 1.83 |
| Revenue Estimate | $490.66M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 2.09 vs est 1.89 ▲ beat |
| 2026-03-31 | USD 1.98 vs est 1.72 ▲ beat |
| 2025-12-31 | USD 2.43 vs est 2.19 ▲ beat |
| 2025-09-30 | USD 1.75 vs est 1.58 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Financials & Fundamentals (CVSA)
| Total Revenue | $1.95B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +9.70% |
| Gross Margin | +57.34% |
| Operating Margin | +19.26% |
| Profit Margin | +12.87% |
| ROE | +18.57% |
| Debt / Equity | 0.63 |
| Current Ratio | 1.09 |
| Total Cash | $406.32M |
| Total Debt | $905.49M |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Ownership (CVSA)
| Insider Ownership | +2.70% |
|---|---|
| Institutional Ownership | +103.83% |
| Shares Outstanding | 33.86M |
| Float | 33.15M |
| Short % of Float | +10.46% |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| LOPE | Grand Canyon Education, Inc. | USD 165.46 | ▲ 3.57% |
| LAUR | Laureate Education, Inc. | USD 38.79 | ▲ 1.25% |
| XXI | Twenty One Capital, Inc. | USD 5.61 | ▼ 4.75% |
| TAL | TAL Education Group | USD 10.46 | ▼ 0.85% |
| LRN | Stride, Inc. | USD 80.68 | ▲ 5.62% |
| MH | McGraw Hill, Inc. | USD 14.8 | ▲ 1.93% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:26 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt